Tom Howard: The Many Legal Hurdles of Cannabis Commerce

Tom Howard is an Illinois-based attorney who specializes in banking and cannabis business, and he is an author who has written two works of historical fiction about the prohibition of cannabis.

In this Ganjapreneur.com podcast episode, Tom joined our host TG Branfalt to talk about the state of the cannabis industry; the hurdles that cannabis professionals, entrepreneurs, and attorneys still face; whether or not the industry should be concerned about a federal crackdown, and a whole lot more.

Tune in via the player below, or scroll further down to read a full transcript of the interview!


Listen to the interview:


Read the transcript:

Commercial: This episode of the Ganjapreneur Podcast is sponsored by Cova, the leading compliant point of sales suite for cannabis retailers and delivery services. Cova was developed to address the needs of retail businesses in California, Colorado, Washington, and Canada. Cova integrates the state traceability systems such as Metric and Leaf, as well as a wide variety of other business tools such as Baker, SpringBig and I Heart Jane. Cova also has built-in compliance features such as looping alerts when purchase limit is exceeded, automated sales tax, and instant age verification with ID scanning. Discover the next evolution of cannabis retail software today at covasoftware.com.


TG Branfalt: Hey there, I’m your host TG Branfalt and you are listening to the Ganjapreneur.com podcast where we try to bring you actionable information and normalize cannabis through the stories of ganjapreneurs, activists and industry stakeholders.

Today I’m joined by Tom Howard. He’s a cannabis industry attorney based in Illinois and the author of Satan Smoke and the Case of U.S. v. Yerbas, which are historical fiction reads which we’ll talk about. But before we do that, I want to get to know about you. How’d you get involved in the cannabis space?

Tom Howard: How did I get involved in the cannabis space? I guess as a freshman or sophomore in college, and I came by cannabis. Everybody kind of grows up and they just take things as they come, so they don’t really question them. By the time I got to law school when I was in my mid-twenties, then you’re learning about laws and what’s behind this marijuana stuff. I started looking into that and it blew my mind.

Just from a legal standpoint of how, and also I was a history major in college. The extent of this whitewashing of truth to ram a government policy that they wanted down the entire population and they would plug their ears to any facts and close their eyes to any facts that would say that they’re wrong, which was just amazing. Have you ever heard of, what is it, part F of the Controlled Substances Act?

TG Branfalt: What specifically does that talk about?

Tom Howard: That’s the one where in order to get the Democrats to go along with it, they actually had to shoehorn this thing onto the CSA, the Controlled Substances Act that has marijuana Schedule 1. They commissioned a study, beginning with the Shafer Report that came out in early 1972, that said oops, we got it wrong and marijuana should actually be decriminalized. They didn’t give a shit.

There was an entire Schedule, or Part F, of the Controlled Substances Act to study marijuana and determine it’s proper classification.

TG Branfalt: Yes. Yes.

Tom Howard: That study said oops, decriminalize it and they never did. That was 1972, so I always think marijuana legalization is right around the corner and when I get really excited I remember that.

TG Branfalt: I do want to talk to you a little bit later on about the federal case that recently occurred, but before that I want to talk to you about federal policy. Let’s start first with the will they or won’t they current federal policy. Last year, Sessions rescinds the Cole memo, there’s no crackdown, but obviously people are worried. Trump just a couple weeks ago at this point, maybe even less, vowed to protect the programs following his row with Senator Cory Gardner over him blocking Justice Department nominees.

In your opinion, with this sort of wishy-washy federal policy, how worried should cannabis industry operators be about federal crackdown?

Tom Howard: About federal crackdown, you see, I don’t think they should be all that worried about it, but that’s only because it’s political suicide. It’s become so popular and so widespread now that, to take an action would be a very untenable position.

TG Branfalt: We also have the FinCEN protections, which the agency released a directive saying we’re not gonna crack down on financial institutions that are doing business with state legal cannabis producers. Despite this, several banks have pulled out of the space. Why do you think banks are so sketched out when they have this federal protection from the agency that enforces their regulations?

Tom Howard: A lot of banks pride themselves on being very conservative lending institutions and employing safe and sound banking principles. In my practice, besides doing marijuana, I pretty much exclusively represent banks in high commercial finance. The reason for that is because technically all of that is money laundering. You are going to try to put a bank in a position to say it’s a safe and sound banking practice to always engage in money laundering, which of course it’s not. That’s one of the reasons why they don’t.

Not only that, Jeff Sessions’ memo from January of this year kind of surprised everybody, including FinCEN, which FinCEN is the Department of the Treasury. Department of Justice of course is a separate one. What happened was, on January 4, Sessions revokes the Cole Memo and all these other memos that T said rescind, but still, it basically means you terminate it.

Then he threw into disarray the FinCEN guidance that expressly relied upon the Cole Memo. Now you have some guidance that’s expressly relying upon something that doesn’t exist anymore because it’s been rescinded. They were really nice and they got flooded with emails and they returned mine. They said that they are still respecting the FinCEN guidance from 2014. You turned to more federal developments with Trump promising Gardner that he’s not going to step up enforcement.

It depends on what you say step up enforcement. Now, that’s why it’s out of Colorado because they have full legalization, full adult use. Regulated, it’s what you should do if you were actually regulating a thing in accordance with the original federal study on it, which gets back to the CSA, it’s hilarious. They regulated marijuana, Congress did, in 1970 without knowing what it did. They said it was like heroin, then they did the study after they equated it to heroin, but they never listened to the results of the study. It’s terrible.

But Schedule 524, something like that, of the budget every year has defunded the war on medical marijuana. The Department of Justice and Jeff Sessions gets no money, no matter what his memo says, to go after the medical marijuana businesses. However, that does not apply to the full legalization, of course. In theory, Jeff Sessions does have some money to go after the people in Colorado that are doing full adult use and that’s why Cory Gardner was holding up Department of Justice nominees until he got that tacit approval from the Donald Trump that he’s not going to enforce the law. Which, in theory he could, he has the money to do it.

TG Branfalt: With this, again, wishy-washy federal policy, that’s where we’re at right now, do you think that cannabis industry operators should be considering moves toward cryptocurrency or cashless card-based systems and what are the pros and cons of making this adjustment?

Tom Howard: The cryptocurrency market’s extremely volatile because you have to convert it into and out of dollars to be able to pay your vendors and whatnot. If you’ve seen the price of bitcoin, it went from 0 to 20,000 and now it’s what, at half that, a little less than half of that. There’s a lot of manipulation in those types of currencies because you have to get them into and out of dollars and that dollars create a problem in the sense that if you got a rack, and by that I mean like $10,000 with a little band around it, you have to watch out for those things because that triggers what they call suspicious activity report for the bank. That bank then has to log it.

Then of course it also gets into the Patriot Act because the Patriot Act trying to stop a lot of that terrorism and terrorism deals in cash. Cash, you can’t trace it. That’s one of the nice things about cash. So you have all those problems that are going on and I can’t even remember what the question was.

TG Branfalt: If you think that industry operators should move towards a cryptocurrency or cashless card based system.

Tom Howard: The cryptocurrency, no, the cashless card based system, yes, because the cashless card based system, you are still using cash, it’s just that you’re setting up a cash free ATM. Then you solve the cash problem. You don’t want to have cash, you want an account with a ledger that just says, have you checked your bank account lately online? It’s kinda nice, right? And you can send money to and from places. Pretty cool. It’s a lot easier to do that than it is with cash but the marijuana businesses are having a problem getting to that point.

If you did one of those cashless card systems, and let’s say your cultivation center, I’m not sure how regulated every different state is, but here we kind of cleave it between cultivation and dispensary. Each one is gonna have different vendors and different payments that they have to pay, but if they could get it on a system, or the best thing that I would recommend is you get the cashless ATM plus a PEO.

In Illinois, the only bank is closing and kicking people out on May 21st. Now you have a real problem in the sense that where do you get a bank account? Are these bank accounts gonna be opened at a bank that’s more amenable, say in like Colorado? Then you have a dispensary in Illinois trying to use a Colorado bank account. That can create some issues, unless of course you only do it in cash free, so you don’t accept any cash, so you never have to make any of those deposits. It’s just all being run from your cash free ATM through your PEO, into your accounts that are in Denver.

Now let’s go over this because that’s money laundering on money laundering on so much fricking money laundering because you’re talking about really trafficking a Schedule 1 substance and then turning it into a ledger, getting around the cash problem, then shipping it intrastate. But they’re being put in this position because I wouldn’t want to do business in straight cash. I would need to buy more safes, right?

That’s one of the problems. Have you heard about dispensaries getting knocked over, like robbed?

TG Branfalt: Yeah, of course.

Tom Howard: Why are they getting robbed? Because that’s where the money is. It hasn’t changed since the 30s. I can’t remember what gangster said. Why do you rob banks? That’s where the money is.

TG Branfalt: You mentioned one of the problems in Illinois, that the banks are shutting down access for cannabis companies and before we went live you were talking to me about what’s really preventing legalization from taking hold in Illinois, through the ballot initiative like it has all over the place. What’s going on? Explain what’s going on in Illinois.

Tom Howard: Alright, Illinois’s got an interesting constitution from 1970. It does not allow for direct questions to to be on the ballot to impact laws unless they’re extremely isolated to one particular provision of the Illinois constitution. I think that mostly has to do with procedural crap. Nothing substantive like, hey should we legalize marijuana, yes or no?

Those types of ballot initiatives you don’t have, but this fall, this November, the people have put a question, a non-binding referendum, let’s call it. You can get a non-binding referendum on the ballot, which is great, because then you can take the pulse of the electorate and it doesn’t matter at all.

Yeah, I know right? Why don’t we just put the Pepsi challenge on there?

TG Branfalt: So the people vote and then it would still be up to the legislature to decide if they want to follow that recommendation of the people?

Tom Howard: Exactly, exactly. It’s a representative democracy, it’s a republic, I guess. Now they’ll know the democratic opinion directly and they’ll be like, yeah maybe we should do this. Of course, right now it doesn’t matter. Your medical card in Illinois, it’s about three months from when you drop your application in the mail until you get your card in the mail, it’s about three months.

The governor has made sure that that stays like that and the governor’s not gonna sign any legalization, even if the people said it, he’d probably still try to veto them. However, we have an election in November and Rauner extremely unpopular and this other billionaire, who’s called JB Pritzker is running against him. He’s a more likable billionaire, to be honest.

TG Branfalt: Is he pro-legalization? Have the gubernatorial candidates made their opinions known?

Tom Howard: Yeah, yeah, yeah, because I liked him on Facebook and he publishes all, because he’s a billionaire, so he’s got his promotional stuff everywhere and one of the ads that I saw was him supporting marijuana legalization. In theory, Illinois, that’s why I said it’s kind of starting to pop here, it’s been stalled, but it’s gotten far enough along that people know that it works. People go to Colorado for trips in winter and all that stuff. There’s been enough canna-tourism so people know.

Then if what happens in fall is, if the referendum is like 60- 70%, it doesn’t matter. I’d be more likely to vote for something that doesn’t matter, right? You don’t even have to think about the consequences. You don’t even have to think about the children, it’s hypothetical. You get 60 or 70% of people who say that we should legalize, you get JB Pritzker in the office, then we might be able to see a bill that has a legitimate shot of passing the Illinois House and being signed by the governor and then going into law, but you still have to understand the lag times on that. The latency period. Colorado didn’t just pass the law and tomorrow you were able to buy marijuana. You have to lay the foundations.

TG Branfalt: And Maine, it’s not gonna take effect until three years nearly.

Tom Howard: Wow.

TG Branfalt: I want to talk to you a bit about patient’s rights. You are an attorney, that’s the sort of thing that you’re an expert in. When cannabis laws are enacted and professional boards often have to issue opinions to allow members of that profession, lawyers for example, to operate in the state or risk penalty in the state program. However, employers in general do not make exceptions for patients, meaning they still get drug tested, they pop positive, they get fired. In the United States, this is the case. What rights do patients have in medical states when it comes to employment and can we look to any of the legal decisions of the last few years, there was one in Massachusetts specifically that I’m thinking about, as precedent?

Tom Howard: Yeah, there have been a couple out of the New England area that did kind of say that there are some rights. However, what you have to do is look at your state’s law first. Start to look at the state’s law because those cases that came down, I believe they were by an administrative law because one of those employer relation boards or something. The opinions from those looked at the state’s laws themselves to determine the rights that the patients had.

Some states have more rights than other states. Florida’s medical marijuana law for patients is very bad. Illinois’ is actually not bad at all. It tries to do both. It tries to protect both the employer’s right to have a drug-free work place, but also the patient’s right to not be discriminated against solely because they’re a cannabis patient. That’s one of the reasons why you really have to kind of read the law, see what it says, and then if you do think you have rights, then you can make your claim and those cases have already brought and made out in the New England area, maybe more will come in Illinois, maybe one of the reasons why it hasn’t is because there’s only about 30,000 card holders here so far.

You have to look at your state’s law and there is some protection, sometimes, from being discriminated against solely for using or having a cannabis card. It’s hard to say one way or the other any definitive binary answer.

TG Branfalt: How do those two things jive? How do you protect both businesses and patients?

Tom Howard: Well, you see a law can say anything you want it to say. I know that’s a glib answer, but at the same time, it’s what the law actually provides and it’s trying to do that and it seems like these two pieces of law can’t be read at the same time and be both carried out, but there’s a lot of arguments that says yes, no, they can actually both be carried out at the same time and we can try to protect both rights of the employer and the employee to the extent that they have.

Now think about it, if the employer doesn’t have the benefit, if it’s drafted in the law that you can’t discriminate against medical marijuana patients solely because they’re a patient and the medical marijuana patient mentions or something that they have that and the boss just goes, I hate cannabis patients, you’re fired. Maybe it’s not gonna be like that, but there might be certain facts about it that it shows no, you only did this because I was a cannabis patient. Maybe then you would actually have some rights, but that’s when you would need to talk to your plaintiff employment attorney.

TG Branfalt: Moving on a little bit, trying to get to a lot of things in one sitting here, tell me about your books. Why did you decide to write historical fiction? You’re obviously an educated guy, you’re an attorney. Why did you focus on the historical fiction rather than writing a fact based book?

Tom Howard: That’s because I wanted them to win in the end. That’s right. That’s right. A lot of the history of it, you have to get back into the 30s and the history of marijuana and trying to find historical record, it’s not like it’s the Declaration of Independence. It’s something that they’ve tried to kind of bury as much as they can. It’s hard to track down those types of records and you can turn it into more of a narrative, something that’s more compelling.

For example, do we really know that the yellow journalism was caused because Hurst, was it Hurst I think, some newspaper baron bought all this farmland and was like leveraged to the hilt and then cannabis was gonna drink his milkshake, if we’re gonna borrow that phrase from There Will Be Blood. Or is that just more historical hokum? There’s those aspects, but then there’s the NORML case, which is something that I call it and the NORML case isn’t one case, it’s a case that NORML’s basically been waging for the past 40 plus years and one of them was just dismissed. It was good. It was a very nice complaint. I can’t remember the name of all the plaintiffs off the top of my head right now. I know one of them was related to the NFL because of brain damage.

TG Branfalt: You’re talking about the Alex Bortelli case? Or Bortel, I believe it is.

Tom Howard: Okay, there you go. Fairly recently dismissed I believe, just a couple months ago or something?

TG Branfalt: Yeah, so your books, Satan Smoke and Versus, which I’m gonna refer to as Versus, the full title is The Case of U.S. v. Yerbas. They both cover distinct eras. One covers the prohibition era and then the other covers the present and Versus actually makes a similar argument to this recent federal court case.

Tom Howard: It’s exactly the same and the only difference is, the reason why that recent court case and why it had to be historical fiction is because I wanted them to win, as opposed to we failed to exhaust administrative remedies. Yay! It’s just so frustrating, because that happens all the time and that’s why I call it the normal case. This was it’s most recent incantation and it was dismissed. There was cases before this and there’ll be a case again.

Trying to exhaust this administrative process is exhausting let’s say.

TG Branfalt: And the way that they lay it out, the way that they laid it out in that case is they showed everybody who’s ever attempted to take this issue of the CCA scheduling and cannabis to the DEA and showing them, and in one case it took nine years just to get a denial.

Tom Howard: Nine years for a denial, I know right.

TG Branfalt: So what was your reaction when the judge tossed it because let me tell you, I’m not a lawyer, I do fancy myself as somebody who does understand legalese and the law and the process a little bit better, just because I’m passionate about it. I had hope. I knew it was misplaced hope when I had that hope, but everything’s laid out there and it seems like they’re in a decent court. I think it was the Ninth Circuit in New York.

Tom Howard: Find the court, find the court. That’s the one where the U.S. v. McIntosh case came and they were able to establish the right to toss Department of Justice’s case against solely medical because of the section of the budget that defunds them. That was a pretty sweet case from a couple years ago.

TG Branfalt: Yeah, yeah, then some of the arguments they were making is this is one of the most comprehensive, if you wanna read a book about the history of prohibition, look no further than the brief that was filed in that case. As an attorney, what was your reaction when the judge tossed it? Were you like, ah that’s expected, because they did allow pieces of it to go forward in the beginning that again, gave you this hope.

Tom Howard: Right. Exactly. I wasn’t all that surprised that the administrative process was yet again, not exhausted. But at the same time, I have more optimism each time they do get to that stage again. Eventually a judge will say alright, cut the crap everybody. This is clearly chicanery, it has no rational basis to the sensible regulation of the commerce of marijuana. What are you doing here? And clearly, why is it all based on these racist lies from the 30s? What are you guys doing? But judges don’t like to draw lines because of the separation of powers issues. Any fricking reason that the judge can not make a ruling as to the constitutionality of the marijuana laws, they’re gonna take that out.

TG Branfalt: What are the constitutional arguments to be made against prohibition?

Tom Howard: The one that we were talking about right now, a lot of them have to do with your due process rights to not have, it’s arbitrary government. The government makes literally no sense. That’s more of your fifth amendment due process right, to be free from that. That is extremely difficult because there’s various standards of scrutiny for striking down a statute and you’re basically trying to strike down the Schedule 1 substance of cannabis. You’re trying to do what the Shafer Study … You’re trying to do Congress should have done in the first place, which was study the darn thing before it regulated it.

But no, that would have been harder to establish this rational basis. So there’s various standards of scrutiny for the striking down of laws. I can’t even recall them off the top of my head now because I’ve learned other law. But commercial regulations like marijuana is the lowest one and it’s got like a 99% failure rate. So you try to shoehorn a little bit of the racial animus into it by doing a rational basis with bite test, which is kind of a thing. It’s also a very low probability, but they didn’t even get to it. They didn’t get to it, they didn’t even address it.

That they don’t address it, that the court didn’t address it, either this makes you still have hope that it’s actually legit, you know? And they’re just trying to do a little bit more time and maybe if they just keep delaying a few more years, Congress will finally strike a line through the controlled substances act solely where is says cannabis. That’s it. The bill is extremely thin. Leave it a law that passes then changes the Controlled Substances Act so that this case Sub 1B4 whatever. Whatever line cannabis is, just red line through.

TG Branfalt: When it comes to the Controlled Substances Act, are you a proponent of descheduling or rescheduling? For people who don’t understand the difference, rescheduling would keep it on the CSA.

Tom Howard: No, like I just said, strike a line through it. Deschedule that stuff because then you allow the states to do it. Now the fun thing is, pro tip here man, back in 1969, marijuana became federally legal for a couple of years, it’s actually what, and I’m gonna apologize for using this verb, fomented the Controlled Substances Act because I guess it was the case of US v. Leary, yeah that guy, Tim Leary. The previous law was the Marijuana Tax Stamp Act and that created a Fifth Amendment self incrimination catch 22 so the high courts struck it.

For a couple of years, it was federally legal, or at least it was federally silent, let’s say. There was no law on it, but it didn’t matter, because in every state, marijuana was a crime in 1969 until the effect of the Controlled Substances Act, which I think was 1971. We can have the inverse of that now. We would strike it and have again, no federal policy, like we did back in 69 to 71. You would have all these state policies. 44 states I believe, have medical marijuana, several more have adult use.

If Schedule 1 is no longer a thing, banking can be accessed because there’s no more money laundering. The way that all these crimes are defined, it doesn’t say marijuana, it says Schedule 1 substance, that’s it.

TG Branfalt: Just having your insight into the history, the actual legal history. When you sat down to write, Yerbas, specifically Versus, how deep did you dig to come up with these arguments or were these arguments that were plodding around in your head as you were studying law?

Tom Howard: When I was in law school, I was a shitty student. I never went to school and I’m not kidding. I wrote two other books in law school, then I got into private practice and this is the book that I wrote in my first year of private practice before I went to Howard and Howard and became a bank attorney. A sophisticated banking attorney. In my first year, I did a lot of this research and wrote Yerbas. You research it as much as you can. You try to get the entire historical record as best as you can, wrench it out of the internet. How much do we trust the internet?

I’m not kidding. Google Scholar really helped. At least you could be doing case law research, but there is a case, and it has to do with, I can’t find it because it was probably an administrative law judge, but do you remember Irv Rosenfeld and the federal marijuana patients?

TG Branfalt: I am not familiar with that one, no.

Tom Howard: There was actually a federal medical marijuana policy from 1978 through 1991 and there’s still four living patients.

TG Branfalt: Oh yeah, you’re talking about the people getting federal joints mailed to their house?

Tom Howard: The joints mailed to them guys. That’s right, yes. That was a case and then you actually had a federal policy and the FDA doing this, what do they call it? IND or something, it was innovative, they’re trying to do research to determine whether or not marijuana has any use and it worked. Some of the people are still alive. That’s just how crazy the whole thing gets. And how convoluted. You’re saying one thing and you’re treating all these people one way and then you’re saying another thing and treating these people a different way. What the heck is it? Then they shut it down in the 90s and that’s when you had medical marijuana start to go into the states, California specifically first.

TG Branfalt: Where can people find out more about you, where can they buy your books? Tell us where to find you.

Tom Howard: Yeah man, go to Cannabis Industry lawyer on YouTube. You can go to our Facebook page, that’s Facebook.com/freethc, that should take you to our Facebook page and after that, Google “Tom Howard marijuana.” I’ll come up.

TG Branfalt: It’s really been great to chat with you man. I really wanna keep in touch. See what you got going on. Maybe if I ever make it out to Illinois, I’ll check in on you.

Tom Howard: Yeah, I would love to go out to the New England area, especially Vermont, I’ve never been out there. I hear it’s beautiful, you just said it.

TG Branfalt: Oh the Green Mountains man, the Green Mountains. Then Burlington’s around Lake Champlain so you can see all the way across to New York, it’s an interesting place, Burlington, Vermont. We just passed our own legalization, not we, the legislature actually did it. We’ll at least be able to grow a little bit and possess without fear of being arrested. That’s good.

Tom Howard: Awesome man. Awesome. Well cool. Thanks so much for having me on. I really had a great time.

TG Branfalt: Absolutely man. Appreciate it. You can find more episodes of the Ganjapreneur.com Podcast in the podcast section of Ganjapreneur.com and in the Apple iTunes store. On the Ganjapreneur.com website you’ll find the latest cannabis news and cannabis jobs updated daily along with transcripts of this podcast. You can also download the Ganjapreneur.com app in iTunes and Google Play. This episode was engineered by Trim Media House. I’ve been your host, TG Branfalt.

End


DEA Reschedules CBD Medication to Schedule 5

The Drug Enforcement Administration announced the rescheduling today of Epidiolex, the first FDA-approved medication derived from the cannabis plant, from Schedule 1 to Schedule 5 under the Controlled Substances Act, CNBC reports.

The move paves the way for United Kingdom-based GW Pharmaceuticals, who manufactures Epixiolex, to begin distributing its new CBD epilepsy medication throughout the U.S.

“We are pleased that the DEA has placed EPIDIOLEX in the lowest restriction Schedule, because it will help ensure that patients with LGS and Dravet syndrome, two of the most debilitating forms of epilepsy, can access this important new treatment option through their physicians.” — Justin Gover, CEO of GW Pharmaceuticals, in a statement

Specifically, the rescheduling applies to CBD that exists in FDA-approved medications; it does not broadly apply to the CBD cannabinoid in all of its forms.

Shares in GW Pharmaceuticals rose 7 percent following news of Epidiolex’s rescheduling.

Epidiolex — an oral solution containing isolated, purified CBD — was approved by the FDA in June. A report in August determined that patients taking Epixiolex can expect to spend about $32,000 per year on the medication.

Early responses to Epidiolex have been positive, and research continues to point to CBD as a largely untapped medicinal resource.

 

End


Cova Software Announces Plan to Retain Retail Cannabis Data in Canada

Cova to host all Canadian Customer Personally Identifiable Information in Microsoft Azure Canada-Central

VANCOUVER BC and DENVER, Sept. 26, 2018 – Retail cannabis point of sale software company and part of the iQmetrix group, Cova Software today announced plans to help retailers in Canada improve protection of retail data and Canadian consumer information by migrating all Canadian cannabis retail data to Azure Canada-Central located in Toronto. The move is set to begin September 27.

Currently, Cova hosts its data in the United States, which is in compliance with PIPEDA and relevant provincial legislation. However, ahead of legalization on October 17, Cova is creating a footprint in Canada to host all customer Personally Identifiable Information (PII). After the move, all Canadian customer data will remain in Canada.

“Cova understands how important data privacy and cannabis retail data protection are to our retailers and their customers, especially given the recent media attention on cross-border travel,” said Cova CEO Gary Cohen. “That’s why we are going the extra mile to secure PII in Canada, over and above the current legal requirements. Moreover, as a Canadian company, we believe a proactive approach to data protection is critical, and by hosting data in Canada we are not only adding an extra layer of security, but we are giving retailers and their customers peace of mind.”

With a move to Canada, cannabis retailers operating throughout the country can trust that Cova Software’s integrated point of sale system is secured safely and in turn can assure customers that their information will remain in Canada, where cannabis is legal.

“We want retailers to understand how critical it is to find a cannabis retail technology partner that can protect sensitive cannabis retail data,” added Cohen. “Because Cova is in the iQmetrix family — a leading provider of retail management in the cellular industry — we have the most robust data protection solution in the cannabis industry. By sharing organizational infrastructure, we leverage this system at a much lower cost, truly taking advantage of the economies of scale that iQmetrix brings.”

The infrastructure that powers Cova Software securely handles more than $16 billion across 200 million transactions every year from Canadian and American companies. Cova is part of an organization that is SSAE18 and PCI-DSS level one complaint and undergoes third-party audits on internal process, change management, physical security, personnel backgrounds, and data infrastructure security.

###

About Cova
Cova is the leading POS solution in the cannabis industry. Cova helps retailers simplify compliance, reduce operational cost, and increase revenue through automated compliance, inventory management, mobile reporting dashboard, and express checkout app. The Cova team is relentlessly pursuing the goal of creating the industry’s first lovable POS. With a growing network of cannabis industry partners including Baker, I Heart Jane, greenRush, Springbig, Enlighten, and Budvue, a seamless tech ecosystem gives retailers access to the best tools available to run their business. Cova’s main offices are in Vancouver BC and Denver.

For more information about the Cova POS suite, Touchscreen Menu, and Express check-out, visit www.covasoftware.com.

End


Millennials

Millennial Generation Prefers Cannabis Over Alcohol

Despite a controversial reputation in some regions, Millennials are increasingly turning to cannabis over alcohol, according to MarketWatch.

Spiros Malandrakis, head of research for alcoholic drinks at industry analysis company Euromonitor International, said alcohol companies that don’t adapt to this shift face huge reductions in future revenue.

Euromonitor estimates the global cannabis market, including illicit markets, at over $150 billion. The alcohol market is currently just $58 billion.

The cannabis revolution is in full swing while the alcohol industry appears to be largely sitting on the fence, drink in hand, occasionally throwing crumpled cans in the general direction of the on-going legalization debate. Visibly intimidated, insular and inherently conservative, large parts of the alcohol industry acknowledge and highlight the dangers to their penetration rates and profitability, but largely fail to see the huge potential behind the plumes of hazy smoke.” — Spiros Malandrakis, via MarketWatch

However, some alcohol companies like Heineken-owned Lagunitas brewing and Constellation Brands, the company behind Corona, have begun to invest in cannabis. The 75-year-old trade organization Wine and Spirits Wholesalers of America has come out in support ending cannabis prohibition, as well.

Millennials are drinking less alcohol than previous generations. A survey of 50,000 young adults and adolescents in the U.S. found that college students who consume alcohol daily fell from 4.3% in 2016 to 2.2% in 2017 — halved in just one year. In 1980, 6.5% used alcohol daily.

Cannabis use, however, is increasing: Yahoo News found in 2017 that a majority of the 55 million cannabis users in the U.S. are millennials, though the share possessed by other demographics is growing rapidly.

Prohibition, however, remains in place for much of the U.S. and some who choose cannabis over alcohol still have a hard time broaching the subject with others. Legalization and normalization can and will fix that, but it will take time.

End


High Times Acquires DOPE Magazine for $11.2 Million

High Times Holding Corp. announced today in a press release that it was acquiring Seattle-based DOPE Magazine; it is the latest in a string of media acquisitions for the longtime cannabis lifestyle brand.

“DOPE is a very strategic acquisition for our portfolio offering key complementary assets to our existing platforms and opening the opportunity for economies of scale to improve performance of all our entire publication group. We couldn’t be more excited to welcome George Jage, Dave Tran and their entire team to the High Times family.” — Adam Levin, CEO of High Times, in the press release

The purchase price is estimated at $11.2 million — this includes 909,129 shares of High Times Class A common stock (valued at $11 per share), $1 million in cash, and an additional $200,000 payable on or about November 10, 2018.

“What DOPE Media has built in such a short time is not only impressive, but needed considering the difficult landscape and legislation brands are faced with today,” said High Times CEO Adam Levin. “We look forward to not only combining our resources but expanding them.”

In a statement published on their website, DOPE team members shared the news about their acquisition with their followers.

“It is with great excitement that we announce today that DOPE Magazine has become part of the High Times Holding Corp.’s family of businesses. … This convergence of forces will create tremendous opportunities for DOPE to reach millions through many new inventive and creative platforms. What won’t change is DOPE’s signature voice, core values, and commitment to normalizing cannabis in our society through exceptional content.”

End


Dr. Dabber Switch and Packaging

Dr. Dabber Switch Review

The first time I saw someone with a butane torch, elaborate glass tubing and what looked like dentistry tools I thought for sure they were working on a science project and not trying to get high. Dabbing can have a high bar for entry for those only familiar with the classic joint or edible — enter the Dr. Dabber Switch.

The Switch doesn’t need a torch, but it’s not an eNail either. The Switch is an induction dabber, which means it uses magnetic fields generated in the sealed body of the rig to heat a ceramic or quartz cup to vaporization temperatures without the extract ever touching sensitive electronic components. The Switch takes an intimidating, dangerous process and makes it approachable and safe by removing the torch and separating the extract and the heat source.

Simply drop your oil, wax or shatter into the induction cup and place the cup into the glass-lined induction chamber. Within 3-5 seconds you can be inhaling cannabis vapor, a huge speed upgrade over conventional methods.

Aside from ease of use, the main benefit from the Switch’s induction heating is a reduced rate of failure. Many conventional dab rigs vaporize cannabis by direct contact with the heating element, or atomizer. These atomizers need replacement every month or two on many rigs — but not the Dr. Dabber.

I had an excellent experience with the Dr. Dabber Switch. I had assumed, upon opening the elaborate package, that there would be a steep learning curve for using the Switch. I was pleasantly surprised to discover that it’s dead simple.

Dr. Dabber Switch

Flip the bottom switch to the oil or flower setting depending on your desired vaporization material, set the power from 1 to 5 depending on desired taste and quantity of vapor and then hold down the power button. The glass induction chamber is lit by colored LEDs that go from red to green as the ceramic cup reaches vaporization temperature. Once they’re green, you just inhale through the water pipe mouthpiece. Bam, high as a kite.

The Switch comes with a variety of tools for dabbing and handling the ceramic cup. The tweezers that come with the unit are a little too bulky to be practical and the glass tipped carb cap is also too big to use for inserting dabs into the chamber. I’ve had great success loading the induction cup outside the unit and then dropping it in directly, so the tools being not quite perfect isn’t a major roadblock.

The only other issue I had with the rig was the ease with which the glass bubbler mouthpiece and carb cap break. They’re made of high-end borosilicate glass but are surprisingly fragile. I accidentally snapped the glass loading tool off the carb cap within a day and within a week I had dropped the glass mouthpiece, shattering it into a million pieces right as I got high. Not ideal. Replacing the mouthpiece cost $75 and I didn’t replace the loading tool but that would’ve cost me another $20 had I opted for replacement. They might have used thicker glass on a rig that costs $400.

And that brings us to another major stopping point for potential buyers — the Switch’s price. $400 is a lot for a dab rig, even an induction one. A basic dabbing system might cost $80-100 for entry-level products, a fraction of the Switch’s cost. However when factoring in the ease and quickness of use, lack of maintenance costs like atomizer replacement and overall utility I think the $400 price point is justified. Undoubtedly, there must have been a lot of engineering that went into designing this rig.

The Dr. Dabber Switch is a strong buy in this reviewer’s opinion. If you’ve been put off dabbing by torches and guesswork, the Switch is made for you. It’s quick, it’s precise, it’s safe and quite frankly it looks and feels awesome in the hand. Order a Switch from the Dr. Dabber website today and begin experimenting with all the awesome extracts that legalization has brought us!

End


Adolescent Cannabis

Cannabis Legalization Does Not Increase Youth Use, Meta-Study Shows

A new review of 55 studies published in the scientific journal Current Addiction Reports shows that adolescent cannabis use does not increase after a state legalizes cannabis, the Marijuana Moment reports.

The meta-study is supported by many other studies that show the same effect — yet still contradicted by some others. Researchers involved with the meta-study said that reports showing teen usage on the rise have often not corrected for the fact that teen usage in those states was already rising prior to legalization. Rates haven’t increased, then, they were just always higher than the national average.

The report looks specifically at “Cannabis use disorder,” which is defined by the World Health Organization as “the continued use of cannabis despite clinically significant impairment, ranging from mild to severe.”

According to the study, adult use has been shown to increase in states with legalization — the rates of cannabis use disorder, however, have not gone up.

“Despite the increase in the prevalence of adult cannabis use, the prevalence of cannabis use disorders among adults in the past year did not change (remaining at 1.5 percent [from 2002 to 2004]). More surprisingly still, the prevalence of [cannabis use disorder] among adults who used cannabis in the past year declined from 14.8 percent in 2002 to 11.0 percent in 2014.” — excerpt from the report, via Marijuana Moment

Researchers theorize that cannabis use disorder is on the decline because the most vulnerable population — adolescents and teens — have also seen their usage rates decline. Many medical studies show that not only are the young most likely to develop cannabis use disorder, they’re also likely to experience the most detrimental side effects of consumption because their brains haven’t fully developed.

Any reduction in adolescent or teen use should swell support for legalization.

End


The flag of Malaysia flies on a clear, blue sky day.

Cannabis Death Sentence Spurs MMJ Legalization Talks in Malaysia

Malaysian leaders are floating the idea of legalizing medical cannabis as activists lash out over a death sentence handed last month to a 29-year-old man, Bloomberg reports.

The Cabinet of Malaysia, the country’s executive branch of government, reportedly discussed potential medicinal benefits of cannabis use during a meeting last week. Xavier Jayakumar, the Minister of Water, Land and Natural Resources, told Bloomberg that informal, preliminary talks about amending the country’s cannabis laws are underway.

The man who was sentenced to death had been convicted of possessing, processing, and distributing medical cannabis oils. According to Jayakumar, the cabinet determined it will overturn his unpopular death sentence — which had prompted the public outrage — but actual legalization talks might not go as smoothly.

“It will take a bit of encouragement and convincing as far as this topic is concerned. My own personal view is that if it’s got medicinal value, then it can be a controlled item that can be used by (the) Ministry of Health for prescription purposes.” — Xavier Jayakumar, Malaysia’s Minister of Water, Land and Natural Resources, via Bloomberg

Jayakumar suggested that keeping the medical use of cannabis separate from recreational use is the core issue that might disrupt the country’s MMJ legalization process.

If successful, Malaysia would be the first country in Asia to legalize medical cannabis.

End


Concord, NH

New Hampshire Predicts $58 Million In Tax Revenue From Legalization

A New Hampshire Department of Revenue Administration report indicates that, with a 15% tax, the state could expect $58 million in tax revenue from cannabis legalization, the Concord Monitor reports.

The report is based on a variety of estimations, including other states with reformed cannabis laws and New York’s recent exhaustive report on legalization.

The lower end of tax revenue estimates at 15% is $26.7 million — still impressive, but significantly lower. Several uncertainties — such as the number of potential cannabis users in the state, how much the cannabis might cost, and how much market share could be immediately recovered from the illicit marketplace — contributed to the wide difference between the high and low tax revenue estimates.

The report was prepared for New Hampshire’s Commission to Study the Legalization, Regulation and Taxation of Marijuana, which was tasked by the state with producing a comprehensive roadmap to legalization by November.

The main goal of the Commission is not to determine whether or not cannabis legalization would generate revenue, but rather if it would generate enough to fund the regulations and enforcement it would require. The Commission’s chairman, state Rep. Pat Abrami, said yes.

The bipartisan Commission is stacked with a wide range of state congress representatives, law enforcement personnel, medical groups, and even anti-cannabis advocacy organizations. The Commission received early criticism for including the wide range of opinions on cannabis legalization, with some arguing it would be impossible to get anything done with so much disagreement among the members.

Democratic state Rep. Renny Cushing, a pro-cannabis member of the Commission, however, has lately praised the group.

“I think that they have drilled down on the topic, they have spoken to people from across the country, states that have gone through the process of legalization, regulation, you know, all the questions have been raised. And it’s been open.” — Rep. Renny Cushing, via the Concord Monitor

The panel has two more meetings left before it must vote on a final report.

End


California Court Rules 5-Year-Old Can Bring MMJ to School

A 5-year-old girl in Santa Rosa, California can attend kindergarten and bring a life-saving, cannabis-based medication with her, a California administrative court ruled on Friday, CNN reports.

5-year-old Brooke Adams — who starts kindergarten this year — has Dravet Syndrome, a rare and severe form of epilepsy. The resulting seizures can be dangerous and unpredictable, but Brooke and her caretakers use cannabis oils to manage the condition: CBD oil as a preventative measure and THC oil as an emergency medication in case her seizures get out of control.

Officials with the Rincon Valley School District School had warned that Brooke — who previously attended a private preschool — would not be able to attend public school with her cannabis medication because the district feared losing federal funds due to the school no longer being a “drug and alcohol-free campus.” The school district instead offered one hour of home instruction per day and the continued services of a licensed vocational nurse who assisted with Brooke’s preschooling.

Her parents, however, wanted the social and academic stimulation of a public school for their daughter, and they decided to take the school district to court.

The Friday court ruling found Brooke and her medication — so long as she is accompanied by the district-appointed nurse — to be within the parameters of California’s Compassionate Use Act and the 2003 Medical Marijuana Program Act.

“I was definitely relieved and excited and emotional. It’s life, life saving, life changing. … I’ve had to stay home with Brooke from vacations and different things and now we can go places as a family, you know, … it’s totally different. I know that I have confidence that the THC is going to stop the seizure … I had no idea what the outcome was going to be once she started having a seizure.” — Jana Adams, mother of Brooke Adams, via CNN

Jennifer Nix, the lawyer who represented the school district during Brooke’s case, said, “We are glad to have clarity and we are glad to serve Brooke. We appreciated that the judge addressed each of our concerns.”

End


Vermont Thieves Rob Hemp Farm Mistaking Crops for Cannabis

Police in Colchester, Vermont report that thieves have been stealing hemp from a local farm, mistakenly believing the plants to be cannabis, according to a WCAX report.

Police say there have been six different intrusions at the farm and that 12 arrests have been made, so far.

The farm in question is Humble Roots Horticulture, operated by farmer Evan Fuller. Fuller said that the farm has heightened security to include 24-hour surveillance, seven days per week, via security cameras. The farm has also acquired pepper ball guns (which fire nonlethal, pepper spray projectiles), bulletproof vests, and an electric fence.

Police spokespeople said that the thieves were looking to steal cannabis plants, not hemp plants, but their ignorance is starting to cost farmers thousands of dollars, as any crop that is stolen — even if it’s found and later returned — must be destroyed.

“It’s really frustrating,” said Fuller, who grows the hemp for oil to be used in balms or salves.

“It’s actually running into the hundreds and thousands of dollars in losses for this Farm, and each plant is worth a lot of money. And people are not only taking, but damaging the crop as they go in as well.” — Colchester Police Chief Doug Allen, via WCAX

Colchester police warned the community via Facebook that anyone considering robbing a hemp farm should know that just two plant’s worth of hemp is valuable enough (about $900) to constitute grand larceny, which is a felony charge.

End


Hemp Farm

Colorado to Consider Removing Hemp Constitutional Amendments

In November, Colorado voters will be asked if they want to remove industrial hemp laws from Colorado’s state Constitution, placing them instead under the state statute, reports KUNC.

The major change would be that laws in the statute can be modified by lawmakers — the Colorado Constitution, however, can only be changed by voters during a statewide election.

The initiative is sponsored by state Sen. Stephen Fenberg, who said he has his eye on upcoming federal hemp legalization and wants Colorado to be prepared. Colorado’s hemp laws require the plant contain 0.03 percent THC or less — a stringent requirement. If the 2018 Farm Bill, which is expected to be signed into law this week, sets a different acceptable THC percentage, Colorado could fall behind in the industrial hemp market if the state isn’t able to modify its hemp laws to match the national standard.

Some Colorado hemp farmers, like Garrett Hause of Lafayette, Colorado, are worried about upcoming changes. Growers in Colorado have spent years carefully cultivating hemp plants that meet the 0.03 percent THC requirement. It’s often a difficult task. Any plant that goes over the THC limit must be destroyed under state law.

Fenberg, however, thinks that the change is inevitable. “There’s a chance that if we don’t do this, the law could conflict in a way that it would actually make it so that our hemp industry suffers,” he said.

End


Hemp Seeds

U.S. Attorney Sues Hemp Farmer Over Seed Sourcing

U.S. Attorney for the Southern District of West Virginia Mike Stuart has filed a civil suit against a hemp farmer in Mason County, West Virginia over alleged violations of the Controlled Substances Act, the Charleston Gazette-Mail reports.

The suit, filed by Stuart to represent the federal government, claims the defendants purchased hemp seeds in Kentucky and brought them over state lines into West Virginia. Stuart said the hemp pilot program in West Virginia requires that all seeds be bought from the West Virginia Department of Agriculture. The suit also claims that required signage and security systems were not installed on the farm.

Various officials in the West Virginia state government, however, contradict Stuart’s claim that seeds must be acquired from the state government, including the Chief of Staff for the state’s Agriculture Commissioner.

The defendants, Matthew Mallory of CAMO Hemp WV and Gary Kale of Grassy Run Farms, are being charged with drug trafficking — not for hemp, but rather marijuana. This is due to overlapping and confusing laws. The federal 2014 Farm Bill provides a structure and laws to help support the development of state-legal pilot hemp industries; each state, however, has separate rules and precedents that often contradict.

One thing is clear in the 2014 Farm Bill, however: Stuart is forbidden from spending federal money “to interfere with or otherwise frustrate the intrastate or interstate transportation of industrial hemp grown or cultivated as part of a Farm Bill-authorized agriculture pilot program.”

Stuart claims the suit isn’t about a stance on industrial hemp, but rather lax regulators. Stuart said, “Based on the action we filed, I think it’s plain that this dispute doesn’t center on a public policy debate about industrial hemp, but on the dangers of lax regulation [and] oversight by a state agency which is trusted by the people of West Virginia to enforce its regulatory scheme.”

West Virginia’s Agriculture Commissioner Kent Leonhardt issued a written statement siding with the farmers:

“The WVDA believes this case could have drastic, adverse effects on West Virginia’s and other states’ industrial hemp programs. This could lead to a loss of a potential cash crop for the Mountain State. As we look to agriculture’s future, we know West Virginia will have to focus on a variety of specialty crops to grow our agricultural economy. Industrial hemp has the potential to be one of those crops with the necessary infrastructure. … We are confused on why the U.S. Attorney’s Office is working so diligently to thwart a growing agricultural industry in the state. Especially, one that Congress has clearly shown its support for, and when there are so many other serious issues affecting West Virginia.” — Kent Leonhardt, via the Charles Gazette-Mail

The 2018 Farm Bill has passed both houses of Congress and is being reconciled from two separate bills into a single version. The Senate version, backed by Mitch McConnell (R-Kentucky) includes clear language that would fully legalize industrial hemp, which is expected to be included in the final version. The previous Farm Bill expires September 30th and lawmakers aim to pass the new bill by then, which may make this lawsuit ultimately pointless.

End


FBI Data Shows Cannabis Arrests Are Increasing

New FBI data shows that cannabis arrests in the U.S. are on the rise despite increasing trends of legalization and/or decriminalization, Tom Angell reports for Forbes.

The FBI logged 653,249 cannabis possession arrests in 2016. In 2017, that number rose to 659,700 — that’s about one cannabis possession arrest every 48 seconds. However, while arrest rates for cannabis possession have increased, they actually decreased for the illegal cultivation or distribution of the plant.

“At a time when more than 100 deaths per day are caused by opioid overdoses, it is foolish to focus our limited law enforcement resources on a drug that has caused literally zero.” — Don Murphy, federal policies director for the Marijuana Policy Project, via Forbes

In 2016, four states (including California, the country’s most populous state) voted to legalize adult-use cannabis — which makes the heightened arrest rates for possession extra concerning.

Meanwhile, more and more Americans lean in favor of federally legalizing cannabis, with the latest poll data suggesting that 60 percent of voters support cannabis law reforms. In fact, cannabis legalization as an issue was more popular with voters than either presidential candidate during the 2016 elections.

Recently, Reps. David Joyce (R-Ohio) and Earl Blumenauer (D-Oregon) said they expect the bill that will ultimately legalize cannabis nationwide will be introduced in Congress next year.

End


Seattle

Seattle Is Removing Prior Cannabis Misdemeanors

The judges overseeing the Seattle Municipal Court have signed an order setting out a process to vacate and remove cannabis misdemeanors from 1996 to the end of cannabis prosecutions, which happened in 2010, Seattle PI reports.

The Seattle Municipal Court is overseen by seven judges. All seven judges on the court signed the order that starts the process for the removal of convictions. City Attorney Pete Holmes filed a motion in April seeking to vacate the convictions, arguing that it was the first step in righting the wrongs created during the war on drugs.

The order will vacate the convictions of 542 people in Seattle who were convicted after the duty of prosecuting cannabis misdemeanors was moved from county district courts to municipal courts.

Holmes became City Attorney for Seattle in 2010 and at that point ceased the prosecution of low-level cannabis crimes.

Seattle officials first announced their efforts to toss the misdemeanor cannabis convictions in February, when Mayor Jenny Durkan penned an op-ed in The Stranger that called for the dismissal of these cases.

“Addressing the wrongs that were caused by the failures of the war on drugs for many years in this country – and particularly the damage wrought on communities of color – won’t happen overnight. We must provide more effective alternatives to prosecution and incarceration through drug and mental health courts, restoring rights and supporting re-entry.” — Mayor Jenny Durkan’s op-ed, via The Stranger

End


Doctor

Studies Suggest Cannabis Doesn’t Kill Pain, But Improves Tolerance

Researchers from Syracuse University have shown in a systematic review of research that cannabis has a positive effect on pain threshold and perceived unpleasantness, though the review showed no perceptible direct pain relief, according to a report appearing in Inverse.

The review used 18 existing studies on cannabis and pain relief that studied a total of 442 adults. A major caveat of the analysis is due to the sample data — like most formal research to date, the 18 studies analyzed focused on THC as the treatment and not other cannabinoids, like CBD.

Also, cannabis used by official research outlets must come from the University of Mississippi — the only entity licensed to produce research-grade cannabis — and the crops grown there are extremely low quality compared to crops grown professionally in state-legal markets, which have much more profound effects and a wider spectrum of cannabinoids.

Researchers said the nature of pain is complex, its expression dependent on many factors beyond the direct perception of pain like anxiety, fatigue and sleep problems. The study’s lead author, Martin De Vita, said that cannabis seems ideal for treating pain in the mind more than the body.

“So while conventional wisdom was ‘cannabinoids relieve pain,’ it is now ‘cannabinoids may relieve specific aspects of pain,'” de Vita said.

Academics call for additional research, pointing out that the sample data limitations in this review are common to the field.

“This systematic review highlights the necessity of loosening restrictions on cannabis research — such as rescheduling cannabis and cannabinoids to Schedule II — so that science catch up with policy. We’re in such a bizarre place right now societally. You can go buy hemp oil that contains CBD from Amazon or a local supermarket, but to try to use those compounds in clinical studies requires an immense regulatory burden.” — Dr. Kevin Boehnke, via Inverse

End


Online Registration Coming to Michigan’s MMJ Program

Medical cannabis patients in Michigan will be able to register and renew their medical cannabis ID cards online starting October 8, according to a report by The Detroit News.

The change also affects doctors, who will be able to register online with the Michigan Bureau of Medical Marijuana Regulation to make medical cannabis recommendations.

Online registration will only be available for patients who do not have a medical cannabis caregiver, or about 69 percent of patients. Patients who register online will be able to:

  • register or renew their medical cannabis ID cards,
  • request a replacement card,
  • pay their registration and/or renewal fees,
  • check the status of an application,
  • update their name and/or address,
  • or withdraw from the registry.

The old method of registration — filing paperwork — will remain in place for any doctors or patients who prefer it to online registration.

“The ultimate win here is reducing the processing time. … Currently, we process all applications within 15 business days of receipt and this could potentially shorten that time frame within a couple of days.” — Andrew Brisbo, director of Michigan’s Bureau of Medical Marijuana Regulation, via Detroit News

The change comes as Michigan voters are set to consider an adult-use cannabis legalization initiative this November and recent polling data suggests that a cannabis victory is likely.

End


Juju Royal

Julian Marley’s Juju Royal Infused Olive Oil Review

We recently received samples of Julian Marley’s Juju Royal Infused Olive Oil. Juju Royal infused olive oils are not infused with THC, but rather basil or rosemary and CBD. The quality of this product is evident top to bottom: Made with US-grown olives hand-picked in Arizona and CBD from hemp grown in Colorado, there is nothing but purity in the bottle.

The oil’s flavor is heavily weighted towards the rosemary and basil, both herbs that pair well with the flavor of the olive. There is a significant amount of CBD in each, over 250mg in the entire bottle. Each two-tablespoon serving contains 30mg, which is a perfect amount to provide the calming and relaxed yet clear-headed feeling that CBD brings.

Juju Royal advocates drizzling the olive oil directly onto fresh tomatoes or vegetables, but they also provide several recipes on their website for more complex preparations. We opted to prepare a simple vinaigrette to use on a salad of fresh greens and vegetables from a local organic garden.

Here’s our recipe for Lemon-rosemary vinaigrette:

  • 3 cloves garlic, peeled
  • 2 tsp. sea salt
  • 3 lemons, juiced
  • ¾ cup Juju Royal Rosemary Extra Virgin Olive Oil

Add peeled garlic, salt and juice of lemon to food processor or blender. Blend until pureéd. With blender or food processor running on high speed, slowly pour olive oil through lid or cover (to contain spray) to emulsify. Place in new container and consume or refrigerate — reblending may be needed if stored for long.

The Juju Royal Olive Oil vinaigrette made for a fantastic salad. The calm, soothed feeling after our fresh lemon-rosemary salad made it clear that only the highest quality, pure CBD oil was used in the bottle. Our next test will be of the Basil-infused CBD Extra Virgin Olive Oil!

Julian Marley's Juju Royal

 

End


Bluebird Botanicals CBD and Hemp Extract Review

Bluebird Botanicals are makers of several Hemp extracts created to allow people anywhere in the world the benefits of pure, healthy cannabinoids.

We recently received several samples of their various products for consideration, including pure CBD distillate and CBD vape juice on top of their whole-plant Hemp extracts. None of the Bluebird Botanicals extracts contain THC, so they won’t get you “high” the way THC-containing cannabis will. It’s just pure medicine.

Bluebird Botanicals pride themselves on the purity of their extracts. All product batches have third party analysis data available for customer review, providing the complete transparency to back up their claims — extremely unusual in the CBD and hemp extract market. Many CBD brands make claims that have no laboratory information backing them up and may even contain contaminants.

We enjoyed our experience with the products. All five provided us with the calming feeling that comes with clean and pure non-THC cannabinoid supplements. The CBD vape juice worked great in our vaporizers and the soft gels were a great way to avoid the somewhat bitter aftertaste that came from both the complete and classic whole-plant extracts. We also experimented with using the extracts as a great way to help come down a bit when we overdid it on THC-containing cannabis — it definitely helped!

The whole plant extracts, however, contain terpenes and other cannabinoids that are proven to have distinct medical effects for different conditions–the taste is a mild concern if they improve your quality of life. The “Complete” extract even contains the forms of cannabinoids only available from decarboxylated–cured or heated–hemp, which truly makes the extract full-spectrum.

If you use CBD for medicinal purposes or want to experiment with the anti-inflammatory properties of the full-spectrum hemp plant, there’s no safer and cleaner way than Bluebird Botanicals. The trust inspired by their transparency of testing and the wide array of products makes their extracts our first choice.

End


Beer

1 in 20 Deaths Caused by Alcohol Worldwide; Still Zero for Cannabis

A new report by the World Health Organization pegs global deaths due to alcohol at 3 million in 2016, making alcohol responsible for 1 out of every 20 deaths, according to a CNN report.

While cannabis has not been studied as deeply, no direct deaths can be attributed to the plant. Some statistics indicate the only significant risks associated with cannabis is for those who start consuming cannabis while younger than 17, with that demographic being more likely to commit suicide. The difficulty with that statistic is that it’s hard to determine if cannabis is the cause of that risk increase, or merely an attempt to medicate conditions that led to the suicide.

Alcohol, however, is responsible for millions of deaths — directly. 28% of those 3 million alcohol deaths were due to injuries, 21% were from alcohol-related digestive disorders and 19% were cardiovascular. The remaining percentage points are from infectious diseases, cancers, mental disorders, and other alcohol-related maladies. Many conditions that, instead of causing, cannabis medicates.

“Far too many people, their families and communities suffer the consequences of the harmful use of alcohol. It’s time to step up action to prevent this serious threat to the development of healthy societies.” — Dr. Tedros Adhanom Ghebreyesus, Director-General of the WHO, via CNN

While it’s clear that alcohol is bad for you, it can be tough for some to let go of beer or wine as a part of their life. Normalization and legalization of adult-use cannabis, with cannabis’ known beneficial effects for fighting addiction, is perhaps just the tool to allow people to kick the indisputably toxic habit of alcohol consumption.

End


Florida Rep. Lambasts DEA’s Cannabis Imports Decision

U.S. Rep Matt Gaetz (R-Florida), who has worked to spearhead legislation in his home state, has lambasted the DEA decision to import CBD and THC capsules from Canada instead of sourcing them from a U.S.-based company, according to MarketWatch.

Earlier this week, Canadian cannabis producer Tilray announced it had received the go-ahead from U.S. officials to import medical cannabis products for an upcoming cannabis study at UC San Diego. Rep. Gaetz, upset by the decision, fumed publicly on Twitter.

Currently, the University of Mississippi is the only federally licensed entity that can grow research-grade cannabis. However, there are dozens of research cannabis cultivation license applications on hold at the DEA right now and Rep. Gaetz — who has repeatedly called for further cannabis research — said the agency’s trepidation is blocking progress for the nation’s most rapidly growing industry.

“We just have to be not so stupid as to impair our own progress,” he told MarketWatch. “There is no reason for us to be creating wealth in Canada for cannabis companies by importing Canadian weed.”

Tilray — which is owned by U.S.-based Privateer Holdings, the parent company behind Leafly, Marley Natural, and several other major cannabis brands — did not push back on Rep. Gaetz’s concerns.

“If Congress changes the law to allow for commercially feasible production of pharmaceutical-grade medical cannabis, we’d be thrilled to create jobs and invest in the U.S. just like we have in Canada. We agree with Representative Gaetz that the U.S. federal government should enable instead of impede this rapidly growing, global and innovative industry.” — Zack Hutson, Tilray spokesperson, via MarketWatch

End


Mariana Islands

U.S. Territory First to Legalize Cannabis By Legislature

On Friday, Gov. Ralph Torres of the Commonwealth of the Northern Mariana Islands (CNMI), a U.S. territory, signed a cannabis legalization bill into law, according to a Forbes by Tom Angell.

The cannabis legislation is the first of its kind, as no other state or U.S. territory has yet to establish a taxed-and-regulated cannabis system via the legislature — all states with adult-use cannabis marketplaces reached that point via direct-to-voter ballot measures. Vermont’s legislature passed a legalization law earlier this year; the law there, however, does not allow for commercial distribution.

CNMI is also the first U.S. jurisdiction to fully legalize adult-use cannabis without first having a medical cannabis program.

“I am proud of our CNMI leadership, citizens and national organizations for working together to thoughtfully develop and approve a progressive piece of legislation that that will improve the quality of life for so many. Together, we are telling the world that we do not feel that our citizens should be stigmatized and criminalized for the responsible adult use of cannabis and that they should no longer be denied access to this life-saving medicine.” — Lawerence J. Duponcheel, co-founder of Sensible CNMI, via Forbes

CNMI’s cannabis law allows for possession of up to one ounce of cannabis flower and plant material; it also legalizes extracts, infused edibles, and similar products. The law creates a structure of licenses for regulators to award to producers, processors, labs, retailers, wholesalers, and cannabis lounges.

Gov. Torres used his line-item veto power to remove some language in the bill before signing it into law, including a previously required $5 permit for cannabis users and a license that would allow a government entity to grow cannabis.

Cannabis advocates are confident that the adult-use legalization in CNMI will add to the already growing pressure on the U.S. federal government to end prohibition.

End


Luke Wilson: Tips for Constructing a Cannabis Grow Site

Luke Wilson is the Director of Field Operations for Canna Advisors, a consultancy firm that helps cannabis entrepreneurs get licensed, optimize facility design, standardize operations, and maximize on their business development opportunities.

In this interview, Luke shares his experience transitioning into the cannabis space, talks about his early work in the industry planning and building cultivation facilities in Canada, gives tips for entrepreneurs who are in the process of building out their own commercial cannabis grow site, and a lot more!

Scroll down to check it out!


Ganjapreneur: What was your background before coming to the cannabis space, and what first prompted your transition?

Luke Wilson: I’m just a country boy from Alabama who got lucky.

Growing up, I never really knew what I wanted to do with my life (as they say), but I always believed I was going to do something big, you know, make a real impact on the world somehow. I’ve never known how or what, I’ve just believed that if I completed college (which I did), kept my head down, worked hard, and put myself in alignment for good things, good things would happen. Eventually they did, but not without a lot of challenges along the way.

First, my family owned and operated a private industrial engineering and construction company for 17 years where I developed the skills to manage multiple projects, budgets, employees, and customers in high pressure and demanding environments. My father did not make it easy on me, always insisting that my brother and I take on the most difficult projects and clients, learning every trade (in the field) from electrical and instrumentation, to piping, concrete, and steel.

My unique background provides perspective and a practical knowledge of construction means and methods that few of my peers can match, if any. My background provides over a decade of progressive and practical experience pertaining to the engineering, construction, and overall management of capital development/improvement projects spanning a variety of markets from heavy industrial manufacturing (such as pulp and paper) to bio-pharmaceuticals (cGMP cleanrooms), cannabis, and recently, commercial distribution.

The Transition: little did I know, “the transition” began in 2012 — two years before I entered the cannabis industry.

I was working one of the worst projects of my life down in Victoria, Texas. It was 100 degrees and 100% humidity as we worked to rebuild a boiler two hours north of the Mexico border. I was living in a hotel for about 4.5 months and doing what I could to keep my marriage together from afar. During my time there I met the man who would go onto change my life 2 years later when he offered me a job with Privateer Holdings.

The “transition” was a legit God-given miracle at a time in my life that I desperately needed it. At the time, I was working at a papermill in Evadale, Texas (equally as challenging as Victoria but more swampy). It was about 5am as I drove down the farm road that led to the mill. The humidity so thick the inside of the windshield was literally dripping onto the dash. It was the same lonely drive I’d made a number of times before, and I certainly didn’t feel like I was on my way to “making a real impact on the world.” I was working hard. I was doing my best to make wise decisions in life, career, and in faith, but I was miserable. I began to pray, and quite honestly it was more of a yell. I yelled at God and angrily shed a tear as I drove to yet another nasty paper mill for another week of “rewarding” work.

At 1pm that day, via Linked-In (initially), God showed up in the form of a man I’d met two years prior in Victoria, Texas. The man who showed up had sold his business in TX and moved to Seattle in search of alternative treatment for his young son who was battling leukemia at the time. He opened a newspaper and saw an article about Privateer Holdings receiving a license to operate in Canada, and noticed their office was just up the street. After a brief visit, my friend from the past made an investment, signed on as Managing Director, and shortly thereafter called me in Birmingham, AL, and asked if I was interested in moving to Nanaimo, BC to build/develop the world’s 2nd cGMP certified facility for the manufacture and research of medical cannabis.

My response, “I wish I could tell you that I can’t be there before Monday, but we’ve got quite a bit to sort out before I start thinking about an international position on Vancouver Island.” $30M dollars, 14 months and many 100 hr weeks later, I left Nanaimo BC with Tilray, the world’s 2nd state of the art facility built for this purpose and employing ~120 local residents. Tilray is now one of the top LP’s in Canada, the 1st cannabis company on the NYSE, and exists in nine countries on five continents.

After my experience building Tilray I was certain of two things:

  1. I’d found my calling, and I was going to be the best capital development consultant in the space.
  2. I had a lifelong dream of raising my family in the mountains of Colorado, and now I had a proven skill set that could support my family there.

As Director of Field Operations for Elevated Standard, LLC, a business unit of Canna Advisors, I direct the team who serves as an extension of the owner, representing their best interests through engineering, construction, staffing, and operational startup/improvement. Working for the leading consulting firm in the space, and living in Colorado, is exactly where I want to be.

When planning or constructing a cannabis grow facility, what are the typical steps in that process?

What are the typical steps people take, or what are the RIGHT steps to take?

Let’s go with the latter… Whether manufacturing indoors, or in a greenhouse, cannabis cultivation must be addressed for what it is — an industrial-agricultural manufacturing process.

The big mistake I’m seeing cultivators make (over and over again) is hiring commercial design build contractors to execute an industrial-ag project. The right approach entails spending smart money for detailed design engineering on the front end, which ensures a smoothly executed construction project on the backend.

How might regulations — and the way they can differ so wildly based on what city, state, province, or country you’re operating in — affect your design process?

The lack of consistency between jurisdictions creates major challenges for the design process because each presents their own unique facility requirements.

State applicants are often scurrying to secure property that meets the regulatory requirements and are typically left with little time to develop well thought-out facility layouts, or realistic engineering and construction budgets.

As a result, a litany of project change orders will typically leave the average Owner/Winner scrambling to find more money to pay for things that weren’t considered, or perhaps weren’t valued during the planning and design phase.

Could you describe your role at Canna Advisors?

I was hired to work with Sue Corser-Jensen to build a new service division for Canna Advisors (CA). Traditionally, CA has been in the business of developing winning applications for cultivation, processing, and dispensary licenses. This new division will go the next step and help clients beyond the time they win a license. We now offer clients owners’ rep services, overseeing everything from engineering and construction, to operational startup, including branding and marketing, staffing, SOP development and implementation, as well as training and operational startup inspection preparation.

What are some other important things that are often overlooked in the construction of a cannabis cultivation site?

Honestly, I’ve seen it all, but it’s not always “overlooking,” often times it’s owners making choices without fully understanding the long-term effects of those decisions or choosing to ignore the potential negative impact of a decision in order to reduce their initial capital investment.  

For example: I’ve seen multi-million-dollar facilities with top notch environmental control, but the locker rooms were in an adjacent building; employees would literally change into their work gear and then go back outside before entering the manufacturing and cultivation space. That is just absurd.

In another instance, I’ve seen breakrooms with direct access to the manufacturing and cultivation floor; breakrooms are a microbiological nightmare, and this shows the architect’s lack of experience in designing clean manufacturing environments.

While a lot of teams struggle to get the floor plan to efficiently allow flow of material and personnel, I see the most mistakes and shortcuts taken around equipment selection, and environmental and process controls, which is the most critical engineering to take place in the construction of a cultivation manufacturing facility. When done correctly, every piece of equipment, and every instrument in the building is tied back to a Building Automation System (BAS) or a Direct Digital Controller (DDC), allowing the Director of Facilities/Maintenance to see what is going on around the facility at any given time. The BAS provides alarms when a room or a piece of equipment is not operating within the programmed specifications or range of tolerance.  It also allows for remote access into your facility and in some cases, remote control of equipment as well.

What are some of the specific differences in regulations that make your job more difficult?

In most cases the design/construction requirements don’t vary a whole lot. Most states require separate entrances for processing/extraction, and cultivation. We typically use facility design and access controls to accomplish this. The real challenge we have is when states implement a rule that pre-determines the number of plants a cultivator can have under one license, and when they limit the products an entity can manufacture and distribute.  

While I oversee the development of our clients’ businesses, that’s not all we do at Canna Advisors. First, we write the business plan, building the financial model, then develop the application. Our technical writing staff has quite the challenge of writing to the specific regulations in each state. There’s no specific portion of the application that is more difficult; however for our writers, the challenge is often conveying the right message within a certain amount of words allowed, or without the opportunity to provide the necessary attachments.

What is the most difficult aspect of your job?

“Know it All” people. People will always be the most challenging aspect of any job, but their stories and development can be the most rewarding.

What has been the most rewarding experience you’ve had so far in the cannabis industry?

Watching Tilray go public on the NYSE was the most rewarding experience I’ve had to date, though I must’ve missed my thank you call from the team (LOL!). I was the 3rd employee at Tilray, and the 16th at Privateer Holdings. I spent many sleepless nights taking Tilray from a poorly planned commercial construction project to a well-oiled machine that could meet the requirements required for cGMP certification.

What advice would you offer somebody who is considering jumping into the industry?

Depending on what role said person is interested in, my opinion will vary. Overall, though, the cannabis industry is by far the most exciting industry I’ve ever worked in. It may be chock full of snake oil, but I’ve never seen so many people actually passionate about what they’re doing. That alone is enough reason to enter any industry on some level. That said, I’m typically dealing with investors, C suite execs, as well as the various leadership positions within an organization. The industry isn’t just for “cannabis” folks, it’s for mainstream adults seeking mainstream employment within a highly competitive and highly regulated market.


Thanks, Luke, for taking the time to answer all our questions! To learn more about Luke Wilson and Canna Advisors, you can visit the company website at ThinkCanna.com.

End


Davinci MIQRO

The Davinci MIQRO Portable Vaporizer Review

Vaporizer manufacturer Davinci originally launched itself onto the dry-herb vaporizer market with the Davinci IQ, a well-designed and easy to use portable vaporizer that has come to be considered one of the best portable options on the market. However, Davinci has kept innovating and as of this summer has released a redesigned and even simpler portable vaporizer: The Davinci MIQRO.

The MIQRO and IQ both utilize a heated chamber to vaporize plant matter, which is fairly standard with portable loose-leaf vapes. However, where Davinci defines itself is simplicity. The MIQRO, just like the IQ, uses “Smart Path” heating technology, which simplifies temperature control into several tiers that slowly increase the temperature as you inhale from several different starting and ending points. It results in maximum extraction of cannabinoids and terpenes with minimum effort. Smart Path vaping is truly where Davinci defines itself, allowing users the best experience without requiring encyclopedic knowledge of vaporizer temperatures.

We received an “Explorer’s Collection” edition of the Davinci MIQRO that comes with a wide variety of accessories and enhancements. Several stickers and fan gear including a Davinci-branded thumb drive, a micro grinder card, dry herb capsule, carrying case and cleaning supplies all shipped in an awesome wooden box that would be great to hold your cannabis supplies. Certainly, the swag that comes with the Explorer’s Collection makes the additional cost worth it.

The MIQRO’s improvements over the IQ start with the size but don’t end there. The MIQRO has had its attached herb chamber tamper, which Davinci calls a “pearl,” redesigned. The pearl allows the user to adjust the volume of the vape chamber so that different amounts of cannabis can be consumed while still being correctly heated. On the IQ the pearl is nearly spherical and is not as firmly attached as it could be. The redesign for the MIQRO has changed the shape to fit more carefully into the chamber and feels more firmly attached. We enjoyed extending the pearl to allow us to take smaller doses of cannabis.

Also redesigned in the MIQRO is the removable and replaceable air path. Now made from Zirconium, it is noticeably easier to clean than the IQ. We had some difficulty removing gunk from some parts of the IQ, which has yet to occur with the MIQRO. The air path itself is also much smaller and built as a straight-edged line, also making it easier to clean.

The only downside for us was the battery life. The package we received, which will be priced at $199, included a second battery that helps limit this issue but we still noticed a lack of power on big draws. We estimate perhaps 5-10 five minute vape sessions per battery. That said, considering the size vs. the IQ, it is a minor issue.

Overall, the MIQRO is a solid buy: the unit-only is expected to retail for $149 and the “Explorer’s” package, which is pictured in this article and was reviewed by us, will retail for $199. As far as sub-$200 portable vaporizers go, it’s difficult to beat the MIQRO. The reduced size and weight, improved “Pearl” tamper, Zirconium air path, as well as low cost make it worth trying out even if you own the Davinci IQ.

End